Renalytix

$24.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.71 (+7.57%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Renalytix and other stocks, options, and ETFs commission-free!

About RNLX

Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom. The listed name for RNLX is Renalytix AI plc American Depositary Shares.

CEO
James McCullough
Employees
—
Headquarters
Penarth, Cardiff
Founded
2018
Market Cap
848.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.16K
High Today
$24.76
Low Today
$22.60
Open Price
$22.60
Volume
101.12K
52 Week High
$24.76
52 Week Low
$9.91

Collections

RNLX Earnings

Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Feb 14, Pre-Market

You May Also Like

PTY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure